APA (7th ed.) Citation

Liu, Y., Xu, L., Hao, C., Wu, J., Jia, X., Ding, X., . . . Zhang, Y. (2022). Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer. Frontiers in Oncology, 12, . https://doi.org/10.3389/fonc.2022.866289

Chicago Style (17th ed.) Citation

Liu, Yunze, Lei Xu, Chuanchuan Hao, Jin Wu, Xianhong Jia, Xia Ding, Changwei Lin, Hongmei Zhu, and Yi Zhang. "Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer." Frontiers in Oncology 12 (2022). https://doi.org/10.3389/fonc.2022.866289.

MLA (9th ed.) Citation

Liu, Yunze, et al. "Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer." Frontiers in Oncology, vol. 12, 2022, https://doi.org/10.3389/fonc.2022.866289.